MedPath

Effect of a Multi-component Education Program on Salt Reduction in Adults

Not Applicable
Completed
Conditions
Hypertension
Blood Pressure
Interventions
Behavioral: Healthy lifestyle program
Behavioral: Salt reduction program
Registration Number
NCT03830021
Lead Sponsor
Academia Cuf Descobertas
Brief Summary

Excess salt intake is a major contributor to high blood pressure, the leading individual risk factor for cardiovascular events, such as stroke, myocardial infarction and heart failure. According to PHYSA study, salt intake in Portugal remains much higher (10.7 g) than recommended by the international health organisations, indicating the need for effective implementation of salt reduction interventions. In Portugal the main source of daily salt intake is added salt during cooking, and salt content in bread, cheese and processed meat.

The objective of this study is to determine the effectiveness of a dietary education program tailored for salt reduction. To assess the effectiveness of the salt reduction program the investigator's will measure changes in salt consumption levels, by evaluating the 24 h urinary sodium excretion.

This study is a consortium-initiated, randomised, simple-blinded, controlled trial designed to assess the effectiveness of a salt reduction program versus generic healthy lifestyle program in the Lisbon Metropolitan Area.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
311
Inclusion Criteria
  • Adults between the ages of 20 and 70.
  • Subjects with or without hypertension, not medicated or medicated with medication and diet stabilized for at least 3 weeks.
  • Responsible for the purchase and confection of their meals.
  • Available to comply with study protocol and sign informed consent.
Exclusion Criteria
  • Pregnant, breastfeeding or planning to become pregnant within the study period.
  • Subjects with current or previous cardiovascular disease (ischemic cardiovascular disease, angina stable or unstable; myocardial infarction, stroke or symptomatic peripheral arteriosclerosis).
  • Subjects with liver or kidney diseases or cancer.
  • Subjects with history of drug, alcohol or other substances abuse, or other factors limiting their ability to cooperate during the study.
  • Subjects with special dietary needs.
  • Health condition that prevents compliance with study requirements.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Healthy lifestyle programHealthy lifestyle programHealthy lifestyle program.
Salt reduction programSalt reduction programSalt reduction program.
Primary Outcome Measures
NameTimeMethod
Change in 24-hour urinary sodium excretion12 weeks

Difference between the intervention and control group in the change in 24-hour urinary sodium excretion from baseline to the end of follow-up.

Secondary Outcome Measures
NameTimeMethod
Change in weight12 week

Difference between the intervention and control group in the change of weight from baseline to the end of follow-up.

Change in waist circumference12 week

Difference between the intervention and control group in the change of waist circumference from baseline to the end of follow-up.

Change in systolic and diastolic blood pressure12 week

Difference between the intervention and control group in the change in systolic and diastolic blood pressure from baseline to the end of follow-up.

Change in salt content in foods purchased12 weeks

Difference between the intervention and control group in the change of salt content in foods purchased from baseline to the end of follow-up.

Trial Locations

Locations (2)

Hospital CUF Infante Santo

🇵🇹

Lisbon, Portugal

Hospital CUF Descobertas

🇵🇹

Lisbon, Portugal

© Copyright 2025. All Rights Reserved by MedPath